What will you learn from the webinar ?
• Amyloid PET Imaging: What are we waiting for?
By Dr. Jacob Dubroff, assistant Professor of Radiology at the Hospital of the University of Pennsylvania.
Dr. Dubroff will provide a synopsis of PET amyloid imaging for suspected Alzheimer’s disease including its use as a biomarker for clinical trials such as IDEAS. He will discuss its prospects for routine clinical use and reimbursement relative to HR 3772, the Medicare Radiopharmaceutical Payment Equity Act of 2019.
• Tau imaging in typical and atypical Alzheimer’s disease
By Dr. Pedro Rosa-Neto, professor of Neurology, Neurosurgery and Psychiatry at McGill University.
Dr. Rosa-Neto will share a study a novel high-affinity tau imaging tracer capable to better identify individuals in the early stages of tau accumulation with the potential to be incorporated in the diagnosis of living patients with Alzheimer's disease.